Distressed M&A: MAC Clauses and Conditionality Pressure Points

MAC Clauses in Distressed M&A: Deal Certainty Playbook

A material adverse change (MAC) clause is a closing condition that lets a buyer refuse to close if the target suffers a defined, serious deterioration between signing and closing. Conditionality is the full set of “ifs” that must be satisfied to close: financing, consents, regulatory clearance, bring-down of reps, covenant compliance, and the rest. In distressed M&A, those two concepts decide who carries the risk of time, and time is the one thing a stressed company can’t manufacture.

Why MAC and conditionality decide outcomes in distressed M&A

Distressed M&A increases the value of conditionality. When solvency is tight, each week of delay raises cash leakage, customer churn, supplier tightening, and lender control. MAC clauses, covenants to operate in the ordinary course, interim-period negatives, and financing-related conditions become the pressure points that decide whether a deal closes, reprices, or ends up being argued about by people billing by the hour.

This note focuses on private deals where one or more stakeholders are stressed. “Distressed” means the target faces imminent liquidity constraints, covenant default risk, or stakeholder enforcement that can change control without shareholder consent. It includes pre-packaged sales, accelerated auctions, creditor-driven dual-track processes, and rescue transactions where the buyer is underwriting time.

Why MAC matters more when the runway is short

MAC clauses allocate two kinds of risk. First, business deterioration risk between signing and closing. Second, process risk: conditionality that becomes an exit ramp when the buyer wants one.

In strong markets, sellers narrow the buyer’s walk rights through carve-outs and tight MAE definitions. In distressed markets, buyers push the other way. They widen the MAC, tighten interim operating covenants, and add bespoke conditions tied to liquidity and stakeholder behavior.

MAC is not a synonym for “I don’t like the deal anymore.” In common-law systems, MAC is an agreed closing condition, usually framed as the absence of a Material Adverse Effect (MAE) on the target, sometimes the combined company, and sometimes the seller’s ability to perform. Delaware remains influential: an MAE is hard to prove, typically must be durationally significant, and usually requires company-specific harm rather than general market weakness. Distress changes the facts, not the legal bar. If liquidity collapses fast, the buyer can tell a company-specific story more easily, if the contract is drafted to capture that deterioration.

Fresh angle: treat “time” as a priced risk, not a legal footnote

Time is often discussed as “timeline risk,” but in distress it is closer to a financial derivative: every extra day changes the odds of survival and the likely cap table at closing. A practical rule of thumb is to draft the MAC and the rest of the closing conditions as if you had to explain, in numbers, what happens if closing slips by 30 days. That forces clarity on cash burn, vendor support, and lender standstill periods, and it discourages vague drafting that only “works” if nothing goes wrong.

MAC versus ordinary course: two levers, different standards

MAC is tested at closing: does an MAE exist? Ordinary course is conduct between signing and closing: did the target do what it promised?

Courts often treat MAC as a high threshold and covenant compliance as a straight contract question. A buyer who wants leverage would rather argue “you breached” than “a judge should find an MAE.” In distress, sellers often cannot operate “normally” without burning cash, which makes a standard “ordinary course consistent with past practice” covenant a trap. That tension has to be fixed on paper, not in a closing call at 2 a.m.

Stakeholders decide where conditionality breaks

Equity sellers want speed and certainty. Buyers want optionality and downside protection. Secured lenders want collateral value preserved and no priming. Trade creditors want continuity and clean payment terms. Regulators can add timing risk that a stressed target cannot survive. Management often supports the buyer who offers retention and a credible closing path, even if the headline price is lower. Incentives show up in drafts. They also show up in the calendar.

MAC architecture: carve-outs decide outcomes

The MAE definition usually includes carve-outs for general risks, often with “disproportionate impact” bring-backs. In distressed deals, the fight is whether liquidity events are “general” or “company-specific,” and whether the buyer’s knowledge at signing neutralizes a MAC claim.

Buyers try to avoid a “known issues” waiver that empties the MAC of meaning. Sellers try to tie MAE to long-term earnings power and exclude short-term liquidity shocks. That’s a rational seller position. It’s also how sellers end up with an agreement that reads well and closes poorly.

Carve-outs matter more than the headline definition. Typical carve-outs include changes in general economic conditions, financial market dislocations, industry conditions, changes in law or accounting, war, pandemics, natural disasters, and cyber incidents. Recent deals spend real ink on inflation, rates, supply chain volatility, and security events. Sellers want those classified as systemic. Buyers want them brought back if the target is hit harder than peers.

Company-specific triggers buyers try to keep inside MAE

Distressed targets often carry customer concentration risk, covenant pressure, and fragile suppliers. Buyers try to specify that loss of a named top customer, loss of a key contract, adverse litigation outcomes, major cyber events, and insolvency-related events count as an MAE or sit outside carve-outs. Sellers resist naming and instead push issues into disclosure schedules with quantified thresholds. That shifts the battle to what was disclosed, when it was disclosed, and whether worsening beyond an agreed level reopens the MAE.

Disproportionate impact and the comparator problem

The “disproportionate impact” bring-back is where systemic risk becomes company-specific. Comparators become contentious. Buyers define “industry” narrowly to make disproportionality easier to show. Sellers define it broadly. If the target is already the weak performer, disproportionality becomes a trapdoor unless drafted with discipline.

Knowledge, foreseeability, and time framing

Knowledge qualifiers and foreseeability language are deal-defining. Buyers in distressed auctions often see liquidity forecasts and lender correspondence. Sellers argue the buyer priced the risk and cannot later claim surprise. Buyers push for explicit “whether or not foreseeable” language and for the idea that disclosed risks can still become an MAE if they worsen beyond agreed levels.

Time framing matters, too. Sellers tie MAE to long-term effects; buyers want rapid deterioration captured because runway can be measured in weeks. If the contract is vague, courts may default to a durational concept, and that can leave a buyer paying for a business that already fell through the ice.

The conditionality stack: where deals actually get decided

Most distressed deals turn less on the MAC and more on the conditionality stack: regulatory approvals, third-party consents, financing, bring-down of reps, covenant compliance, absence of injunctions, delivery of closing deliverables, and any special liquidity conditions.

Financing conditionality and reverse termination fees

Financing conditionality is the sensitive variable in private deals. Sponsors often avoid a “financing out” and instead use a reverse termination fee (RTF). In distress, sellers and creditors demand tighter commitment: equity commitment letters, limited conditions to funding, and clear linkage between lender funding conditions and acquisition closing conditions. If the target cannot survive a long closing, sellers often accept a lower price for a higher-certainty funding package. That’s not charity; it’s arithmetic.

Buyers can still create functional financing optionality without an explicit financing out. The common method is matching the acquisition agreement’s conditions to the debt commitment’s conditions and then pointing to a failed lender condition as the reason closing can’t happen. Sellers respond by pulling the commitment into the acquisition agreement: require the buyer to enforce it, restrict amendments without seller consent, and impose “hell or high water” efforts to obtain funding. Each move affects close certainty, timeline, and who bears the cost of a lender’s change of heart.

Debt commitments carry their own MAC concepts. Commitment letters and credit agreements can include flex, market conditions, and “no MAE” conditions tied to the target. Sellers often underestimate this. The buyer may want to close; lenders may not. A practical fix is transparency: sellers and creditors request to see the debt commitment and its conditions precedent, and they press for a “certain funds” style structure where feasible. Full UK-style certain funds remains uncommon in U.S. private M&A, but distressed situations push parties toward partial convergence because timing is existential.

Regulatory timing can be a deal breaker

Regulatory conditionality becomes lethal when runway is short. Even if antitrust risk is low, time to clearance can exceed the target’s liquidity. Buyers can exploit this by insisting on a long-stop date the target can’t fund. Sellers counter with shorter outside dates, ticking fees, and interim liquidity covenants that force the buyer to close quickly or pay for delay. For a distressed seller, the highest-value term is often not the last dollar of price; it’s the shortest path to a cleared closing.

Ordinary course needs to match the survival plan

The ordinary course covenant is often the central drafting conflict. “Operate in the ordinary course consistent with past practice” does not fit a target that must cut capex, renegotiate leases, slow payables, reduce inventory, and restructure headcount. Left unmodified, the covenant sets up a breach based on survival actions.

Sellers can solve this three ways. Define “ordinary course” to include specified crisis actions. Add consent mechanics with deemed consent on tight timelines. Or replace the covenant with a tailored promise to operate under a liquidity preservation plan attached as an exhibit. The impact is direct: fewer discretionary disputes, fewer waiver negotiations, and higher close probability.

Buyers worry sellers will extract value before closing, including selective payments to insiders, accelerated retention, opportunistic settlements, and affiliate transactions. Address that with explicit negative covenants and cash controls, not vague “ordinary course” phrasing.

Leakage limits: Restrict dividends, distributions, and related-party transactions, with clear dollar thresholds and defined exceptions.
Cash discipline: Require consent for extraordinary payables management, asset sales, and unusual settlements that change the cash curve.
High-frequency reporting: Provide weekly liquidity updates, a rolling 13-week cash flow forecast, and immediate notice of defaults and enforcement threats.
Confidential access: Use tight confidentiality, limited distribution lists, and audit trails to reduce destabilizing internal and external leaks.

Consents: the hidden condition that kills closings

Third-party consents often become the real MAC. Distressed companies carry more change-of-control triggers, landlord termination rights, supplier insecurity clauses, customer step-down provisions, and licensing issues. The acquisition agreement must sort consents into “conditions to closing” versus “post-closing covenants.” Too many pre-close consents can sink the deal. Buyers should prioritize consents tied to core value. Sellers should push non-critical consents into transition arrangements, indemnities, or price adjustments.

Anti-assignment and ipso facto provisions can shift the map. Some insolvency-triggered terminations are limited in bankruptcy contexts; change-of-control provisions may still bite. If the deal is an asset sale versus a statutory merger, consent requirements change. Deal form becomes an execution tool.

Jurisdiction matters because MAC litigation risk is venue risk. Delaware law remains a reference point for MAE interpretation in U.S.-style private deals. Cross-border deals sometimes split governing law between the acquisition agreement and financing documents, which creates interpretive mismatch. In distress, avoid a structure where the buyer must close under one regime while lenders can exit under another. That’s how you end up owning a problem you can’t finance.

Bankruptcy overlays: MAC recedes, process conditions rise

Chapter 11 sales in the U.S., often under section 363, change risk allocation. A sale order can cleanse liabilities and provide free-and-clear relief, but it brings court process, objection risk, and bidding procedures. MAC clauses look different in 363 asset purchase agreements because the process and creditor oversight reduce post-signing operational drift, and timelines are often accelerated. The conditionality stack shifts from MAE debates to court approvals, cure amounts for assumed contracts, bid protections, and financing certainty.

Pre-pack and pre-negotiated restructurings embed M&A in a plan. Conditionality then includes plan confirmation, creditor voting outcomes, and regulatory approvals that may not align with cash runway. Buyers must diligence capital structure and voting mechanics like they expect a contested process. Sellers must manage information leakage and keep narratives consistent across creditors and regulators.

Documents, remedies, and the terms that actually move risk

In distressed M&A, documents map directly to execution risk. The acquisition agreement governs MAE, covenants, closing conditions, termination rights, and remedies. Disclosure schedules can decide whether a liquidity issue is a disclosed risk or a breach. Debt and equity commitments decide whether the buyer can fund. Limited guarantees decide who can be sued. Side letters with key lenders or customers can carry more value than a small turn of purchase price.

Remedies are the deal’s real risk allocation. Sellers want specific performance when conditions are met because damages are useless if the company collapses. Buyers want termination rights with capped exposure and will argue specific performance should not apply if financing is unavailable. The outcome often turns on whether the seller can directly enforce commitments and whether the buyer must pursue lenders.

Reverse termination fees price optionality. In distress, a seller should resist a fee that is small relative to the harm of a failed process. A broken sale process can accelerate customer departures, tighten suppliers, and trigger lender enforcement. Buyers should assume that if they want a low RTF, they will pay elsewhere: tighter conditions, fewer exits, stronger interim covenants, or a lower price.

Working capital and net debt mechanics also become levers. A distressed company can stretch payables, draw revolvers, or accelerate collections to survive. Buyers argue for normalized pegs and debt-like treatment for arrears. Sellers argue those actions were required and should not be penalized. The agreement must define “debt” to capture distressed items that behave like debt: factoring, supply chain finance, deferred payroll taxes, and unpaid bonus accruals. Get that wrong and you get a closing-day fight over definitions, not value.

Practical “kill tests” for close certainty

A few tests screen whether a distressed deal closes without value-destructive conflict.

Runway test: Can the target survive to the outside date plus a buffer under a downside case, without relying on waivers?
Conditionality alignment: Do acquisition closing conditions and financing conditions match, with lender failure risk clearly allocated?
Ordinary course realism: Does the interim covenant permit the survival plan: headcount actions, capex cuts, supplier renegotiations, and collections discipline?
Consent criticality: Are consents sorted into must-have pre-close versus manageable post-close, with a plan for each must-have?
Remedy credibility: If the buyer refuses to close, does the seller have a fast remedy with real economic weight?

Key Takeaway

Distressed M&A doesn’t reduce disputes over MAC and conditionality. It makes them decisive because time is not neutral. The highest-value work is not adding conditions. It is drafting a package that matches the operating reality of a stressed business, aligns financing with closing mechanics, and limits discretionary off-ramps that invite opportunism.